Binfeng Lu

12.1k total citations · 2 hit papers
141 papers, 9.7k citations indexed

About

Binfeng Lu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Binfeng Lu has authored 141 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Immunology, 67 papers in Oncology and 33 papers in Molecular Biology. Recurrent topics in Binfeng Lu's work include Immune Cell Function and Interaction (53 papers), Cancer Immunotherapy and Biomarkers (37 papers) and Immunotherapy and Immune Responses (28 papers). Binfeng Lu is often cited by papers focused on Immune Cell Function and Interaction (53 papers), Cancer Immunotherapy and Biomarkers (37 papers) and Immunotherapy and Immune Responses (28 papers). Binfeng Lu collaborates with scholars based in United States, China and Germany. Binfeng Lu's co-authors include Richard A. Flavell, Jingting Jiang, Yibei Zhu, Xueguang Zhang, Changping Wu, Guangbo Zhang, Lujun Chen, Xueguang Zhang, Min Yang and Robert L. Ferris and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Binfeng Lu

138 papers receiving 9.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neuronal Activity–Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis

2009 720 citations K. Dengke, Mi‐Hyeon Jang et al. Science profile →
Autophagy Reduces Acute Ethanol-Induced Hepatotoxicity and Steatosis in Mice

2010 423 citations Binfeng Lu et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Binfeng Lu	4.5k	3.5k	3.1k	1.1k	927	141	9.7k
Gerhard Müller‐Newen	3.9k 0.9×	4.6k 1.3×	3.8k 1.2×	748 0.7×	470 0.5×	125	10.2k
Ansuman T. Satpathy	5.2k 1.2×	2.8k 0.8×	4.0k 1.3×	669 0.6×	777 0.8×	86	9.8k
Ken Yamaguchi	3.3k 0.7×	4.4k 1.3×	2.8k 0.9×	1.2k 1.0×	373 0.4×	312	9.5k
Nathalia A. Giese	2.1k 0.5×	4.0k 1.1×	3.6k 1.2×	912 0.8×	599 0.6×	155	9.0k
Jonathan D. Powell	9.5k 2.1×	3.8k 1.1×	5.6k 1.8×	1.2k 1.1×	1.0k 1.1×	173	17.1k
Andrés Hidalgo	6.2k 1.4×	1.7k 0.5×	2.9k 0.9×	821 0.7×	509 0.5×	127	11.2k
Gen‐Sheng Feng	5.4k 1.2×	3.3k 0.9×	9.1k 2.9×	1.2k 1.0×	592 0.6×	195	14.3k
Nicholas D. Huntington	7.0k 1.5×	3.0k 0.9×	2.5k 0.8×	965 0.8×	368 0.4×	111	10.1k
Jenny P.‐Y. Ting	4.3k 1.0×	1.5k 0.4×	4.7k 1.5×	879 0.8×	376 0.4×	126	10.3k
Fabio Malavasi	6.1k 1.3×	3.5k 1.0×	4.5k 1.4×	1.6k 1.4×	480 0.5×	357	16.7k

Countries citing papers authored by Binfeng Lu

Since Specialization

Citations

This map shows the geographic impact of Binfeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binfeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binfeng Lu more than expected).

Fields of papers citing papers by Binfeng Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binfeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binfeng Lu. The network helps show where Binfeng Lu may publish in the future.

Co-authorship network of co-authors of Binfeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Binfeng Lu. A scholar is included among the top collaborators of Binfeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binfeng Lu. Binfeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Jiang‐Nan, et al.. (2025). The effect of digital inclusive finance on the development of the green economy in china: A panel data analysis. Environment Development and Sustainability. 27(12). 29075–29103.

Dai, Liang, Zixuan Song, Binfeng Lu, et al.. (2025). Targeted and Synergistic Codelivery of Chemotherapeutic and Nucleic Acid Drugs by Liposome-Coated MPDA Nanoparticles for Advanced Prostate Cancer Treatment. ACS Applied Materials & Interfaces. 17(6). 8875–8885. 1 indexed citations

Zheng, Yi, et al.. (2024). Targeting reactive oxygen species to ameliorate T cell-mediated inflammation in dry eye syndrome: a novel therapeutic approach. RSC Advances. 14(49). 36804–36815. 1 indexed citations

Luo, Zhangyi, Yixian Huang, Neelu Batra, et al.. (2024). Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature Communications. 15(1). 255–255. 30 indexed citations

Chen, Yuang, Yixian Huang, Zhangyi Luo, et al.. (2022). Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy. Nature Nanotechnology. 18(2). 193–204. 87 indexed citations

Guo, Weiwei, Ghanshyam S. Yadav, Zehua Wang, et al.. (2022). Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response. Science Advances. 8(49). eadd0005–eadd0005. 10 indexed citations

Chen, Xueer, Lujia Chen, Cornelius Kürten, et al.. (2022). An individualized causal framework for learning intercellular communication networks that define microenvironments of individual tumors. PLoS Computational Biology. 18(12). e1010761–e1010761. 3 indexed citations

Chen, Yuang, Yixian Huang, Haozhe Huang, et al.. (2021). Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination. Molecular Therapy — Nucleic Acids. 26. 594–602. 11 indexed citations

Wan, Zhuoya, Runzi Sun, Yang‐Wuyue Liu, et al.. (2021). Targeting metabotropic glutamate receptor 4 for cancer immunotherapy. Science Advances. 7(50). eabj4226–eabj4226. 23 indexed citations

10.

Chen, Lujun, Runzi Sun, Dachuan Zhang, et al.. (2020). Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy. Cancer Immunology Research. 8(11). 1381–1392. 41 indexed citations

11.

Liu, Zhuqing, Elizabeth L. McMichael, Gulidanna Shayan, et al.. (2018). Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients. Clinical Cancer Research. 24(18). 4529–4538. 91 indexed citations

12.

Shi, Liangrong, Lujun Chen, Changping Wu, et al.. (2016). PD-1 Blockade Boosts Radiofrequency Ablation–Elicited Adaptive Immune Responses against Tumor. Clinical Cancer Research. 22(5). 1173–1184. 244 indexed citations

13.

Ferris, Robert L., Binfeng Lu, & Larry Kane. (2014). Too Much of a Good Thing? Tim-3 and TCR Signaling in T Cell Exhaustion. The Journal of Immunology. 193(4). 1525–1530. 123 indexed citations

14.

Li, Gang, Qianting Yang, Yibei Zhu, et al.. (2013). T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells. PLoS ONE. 8(6). e67401–e67401. 57 indexed citations

15.

Yang, Qianting, Gang Li, Yibei Zhu, et al.. (2011). IL‐33 synergizes with TCR and IL‐12 signaling to promote the effector function of CD8⁺ T cells. European Journal of Immunology. 41(11). 3351–3360. 166 indexed citations

16.

Wang, Jiamin, Fang Li, Guangbo Zhang, et al.. (2010). Two Novel Monoclonal Antibodies Against Human CD133-2: Distinct Epitopes and Agonist Activity to Enhance Growth of CD133 Expression Cells In Vitro. Hybridoma. 29(3). 241–249. 4 indexed citations

17.

Dengke, K., Mi‐Hyeon Jang, Junjie U. Guo, et al.. (2009). Neuronal Activity–Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis. Science. 323(5917). 1074–1077. 720 indexed citations breakdown →

18.

Zhou, Shiyong, Fang Xie, Hongya Wu, et al.. (2009). Characterization and Application of Two Novel Monoclonal Antibodies Against Human CXCR4: Cell Proliferation and Migration Regulation for Glioma Cell Line in vitro by CXCR4/SDF-1α Signal. Hybridoma. 28(1). 33–41. 10 indexed citations

19.

Søndergaard, B.C., Kim Henriksen, Søren Østergaard, et al.. (2005). A2 GADD45β is novel mediator of MMP-13 gene expression during chondrocyte hypertrophy. Osteoarthritis and Cartilage. 13. S12–S13. 1 indexed citations

20.

Li, Xiaoyu, Xia Bu, Binfeng Lu, et al.. (2002). The Hematopoiesis-Specific GTP-Binding Protein RhoH Is GTPase Deficient and Modulates Activities of Other Rho GTPases by an Inhibitory Function. Molecular and Cellular Biology. 22(4). 1158–1171. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact